Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Sara T'Sas
Profile
Projects
Publications
Activities
Awards & Distinctions
12
Results
2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia
Lisa Demoen
Filip Matthijssens
Lindy Reunes
Bruno Palhais
Béatrice Lintermans
Sara T'Sas
Igor Fijalkowski
Joachim Taminau
Muluembet Z. Akele
Siska Van Belle
et al.
A1
Journal Article
in
SCIENCE ADVANCES
2024
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia
André Pedro Pinto De Almeida
Sara T'Sas
Luca Pagliaro
Igor Fijalkowski
Wouter Sleeckx
Hannah Van Steenberge
Raffaella Zamponi
Béatrice Lintermans
Wouter Van Loocke
Bruno Palhais
et al.
A1
Journal Article
in
HEMASPHERE
2024
Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia
Stien De Coninck
Juliette Roels
Béatrice Lintermans
Sara T'Sas
Tom Taghon
U
Journal Article
in
Blood Advances
2024
2023
Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma
Lien Provez
Tom Putteman
Mattias Landfors
Juliette Roels
Lindy Reunes
Sara T'Sas
Wouter Van Loocke
Béatrice Lintermans
Stien De Coninck
Morgan Thenoz
et al.
A1
Journal Article
in
CANCERS
2023
2022
Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia
Steven Goossens
Anje Cauwels
Tim Pieters
Renate De Smedt
Sara T'Sas
André Pedro Pinto De Almeida
Willem Daneels
Pieter Van Vlierberghe
Jan Tavernier
A1
Journal Article
in
HAEMATOLOGICA
2022
Myb drives B-cell neoplasms and myeloid malignancies in vivo
Tim Pieters
André Pedro Pinto De Almeida
Sara T'Sas
Kelly Lemeire
Tino Hochepied
Geert Berx
Alex Kentsis
Steven Goossens
Pieter Van Vlierberghe
A1
Journal Article
in
BLOOD ADVANCES
2022
2021
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
Tim Pieters
Sara T'Sas
Stijn Vanhee
André Pedro Pinto De Almeida
Yasmine Driege
Juliette Roels
Wouter Van Loocke
Willem Daneels
Mathijs Baens
Arnaud Marchand
et al.
A1
Journal Article
in
JOURNAL OF EXPERIMENTAL MEDICINE
2021
SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)
André Pedro Pinto De Almeida
Tim Pieters
Sara T'Sas
Steven Goossens
Pieter Van Vlierberghe
C3
Conference
2021
2019
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
Tim Pieters
Sara T'Sas
Lisa Demoen
André Pedro Pinto De Almeida
Lieven Haenebalcke
Filip Matthijssens
Kelly Lemeire
Jinke D'Hont
Frédérique Vanrockeghem
Tino Hochepied
et al.
A1
Journal Article
in
SCIENTIFIC REPORTS
2019
ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
Steven Goossens
Jueqiong Wang
Cedric Tremblay
Jelle De Medts
Sara T'Sas
Thao Nguyen
Jesslyn Saw
Katharina Haigh
David J Curtis
Pieter Van Vlierberghe
et al.
A1
Journal Article
in
HAEMATOLOGICA
2019
2016
Cyclin D2 overexpression recapitulates mantle cell lymphoma in mice
Tim Pieters
Steven Goossens
Sara T'Sas
Geert Berx
Jody J Haigh
Pieter Van Vlierberghe
C3
Conference
2016
Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL
Tim Pieters
Steven Goossens
Sara T'Sas
Lieven Haenebalcke
Tino Hochepied
Béatrice Lintermans
Sofie Peirs
Filip Matthijssens
J Haigh
Geert Berx
et al.
C3
Conference
2016